TruScreen Group Limited

Equities

TRU

NZTRUE0001S7

Advanced Medical Equipment & Technology

End-of-day quote New Zealand S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
0.02 ^NZD	0.00%		+11.11%	-13.04%

13/03	Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5%	MT
08/03	New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire	MT

TruScreen Group Limited Reports Earnings Results for the Half Year Ended September 30, 2022

November 29, 2022 at 02:50 am IST

TruScreen Group Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported net loss was NZD 1.22 million compared to NZD 1.26 million a year ago. Basic loss per share from continuing operations was NZD 0.0034 compared to NZD 0.0035 a year ago.

Latest news about TruScreen Group Limited

Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5%	13/03	MT
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire	08/03	MT
TruScreen to Start Clinical Evaluation Trials for Cancer Screening Device	08/03	MT
Truscreen Close to Raising NZ$500,000	04/03	MT
New Zealand Shares Close the Week in the Green; Port of Tauranga’s Fiscal H1 Revenue Falls	23/02	MT
Truscreen's CEO Resigns	23/02	MT
TruScreen Group Limited Announces CEO Changes	23/02	CI
Truscreen Group to Offer Pro-Rata Renounceable Rights Issue; Shares Plunge 11%	12/02	MT
TruScreen Secures Reimbursement Approval in Saudi Arabia for Cervical Cancer Screening Device; Shares Rise 4%	12/02	MT
Truscreen Secures Regulatory Approval to Expand Use of Cancer Screening Device in Mexico; Shares Rise 4%	07/02	MT
Truscreen Group Limited Receives Approval in Mexico to Enter Public Health Sector	07/02	CI
TruScreen's Nine-Month Revenue Surges 34%	25/01	MT
Truscreen Group Limited Announces Sales Results for the Nine Months Ended 31 December 2023	25/01	CI
New Zealand Bourse Regulator Slaps TruScreen a Fine on Audit Committee Breach	03/01	MT
TruScreen Wins Polish Start-Up Challenge; Shares Rise 5%	14/12	MT
New Zealand Shares Rebound on Wednesday, Air New Zealand Expects Fiscal H1 Earnings to be on the Lower End of Guidance	13/12	MT
TruScreen's Diagnostic Device Lands Spot in Vietnam Health Ministry's Approved Technical List; Shares Rise 5%	13/12	MT
TruScreen Secures Purchase Order from Zimbabwe	06/11	MT
TruScreen Group Limited Confirms Receipt of Further Purchase Order from Zimbabwe for SUS	06/11	CI
TruScreen Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	06/11	CI
Truscreen Logs 33% Growth in Fiscal H1 Revenue	12/23/12	MT
TruScreen Group Limited Announces Sales Results for the First Half of 2024	12/23/12	CI
Middle Eastern Hospital Network Adopts TruSreen’s Cervical Cancer Screening Device in Saudi Arabia	18/23/18	MT
TruScreen Group Limited Announces Dr Sulaiman Al-Habib Medical Group Installs First Tranche of Four TruScreen Devices for Commercial Use, for Screening of Cervical Cancer in Saudi Arabia	18/23/18	CI
TruScreen Group Limited Reports Sales Results for the First Quarter Ended June 2023	15/23/15	CI

Chart TruScreen Group Limited

Duration

Period

More charts

Company Profile

Truscreen Group Limited is a New Zealand-based medical device company. The Company is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Companyâs cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. It also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.

Sector

Advanced Medical Equipment & Technology

Calendar

29/05/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
TRUSCREEN GROUP LIMITED	-13.04%	67.47L
THERMO FISHER SCIENTIFIC	+10.96%	23TCr
DANAHER CORPORATION	+15.08%	20TCr
INTUITIVE SURGICAL, INC.	+18.50%	14TCr
BOSTON SCIENTIFIC CORPORATION	+29.79%	11TCr
SIEMENS HEALTHINEERS AG	+2.36%	6.53TCr
EDWARDS LIFESCIENCES CORPORATION	+16.63%	5.44TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.96%	5.09TCr
AGILENT TECHNOLOGIES, INC.	+9.18%	4.48TCr
GE HEALTHCARE TECHNOLOGIES INC.	+3.21%	3.68TCr

Other Advanced Medical Equipment & Technology